DIAGNOSED ARACHNOIDITIS PATIENTS
Calmare Pain Therapy Treatment (Scrambler Therapy) to Treat Diagnosed Cases of Arachnoiditis and Reduce Chronic Neuropathic Pain Symptoms
What is Arachnoiditis?
Arachnoiditis is a chronic pain disorder caused by the inflammation of the arachnoid membrane and subarachnoid space that surround the nerves of the spinal cord. The inflammation can cause the meninges to adhere to the spinal cord and nerve roots.
Because the nerve roots are affected, symptoms such as numbness, tingling, and burning pain is often felt in the lower back or legs.
Severe cases of arachnoiditis can result in the loss of motor function, loss of bladder and bowel control and even paralysis. Arachnoiditis can arise from infection, direct spinal injury, and chronic compression of the spinal nerves or invasive spinal surgeries.
Study Conducted by
Dr. Michael J. Cooney
Rutherford Allied Medical Group / Calmare Therapy NJ
Rutherford, NJ (10 miles from New York City)
Study Start Date
January 15, 2015
Calmare Therapy NJ / Rutherford Allied Medical Group, is one of only ten certified providers of Calmare Pain Therapy Treatment®, an FDA-cleared, non-invasive, pain-free, drug-free technology to treat patients suffering from several types of long-term, high-intensity pain.
Scope of 2015 Calmare Study
We are conducting a free, 10-treatment (one 45-minute daily therapy session) clinical trial study for pre-qualified patients suffering from diagnosed Arachnoiditis to determine the efficacy of scrambler therapy as a viable treatment solution for condition-induced neuropathy.
Pre-approved study patients must be available to undergo a protocol of 10 treatments once per day. There is no charge for the series of 10 treatments.
Travel, daily transportation, meals and accommodations are at the expense of the trial patient.
People who agree to take part in the study are asked to sign the informed consent form. However, signing the form does not mean people must stay in the study. People can leave the study at any time—either before the study starts or at any time during the study or the follow-up period. The informed consent process continues throughout the study. If new benefits, risks, or side effects are discovered during the study, the researchers must inform the participants. They may be asked to sign new consent forms if they want to stay in the study.
To Apply / Contact Us / For More Information
To find out more and determine if you may be an appropriate candidate for the no cost study, please contact:
Dr. Michael Cooney
Calmare Therapy NJ / Rutherford Allied Medical Group
(201) 933.4440 | email@example.com